Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies
Figure 3
Enhancement of endometrioid carcinoma of the ovary in a postmenopausal patient. Postmenopausal patient in her early 60 s with moderately differentiated endometrioid carcinoma of the left ovary. (a) Precontrast and (b) subtraction image of first post contrast phase axial 3D gradient echo T1 weighted images of the pelvis show a heterogeneous left pelvic mass with enhancement of the nodular soft tissue component (arrow). The mass had a proteinaceous cystic component and also invaded the uterus. Percentage of lesion enhancement on the first post contrast phase was 156.8% for Reader 1 and 117.7% for Reader 2. Percent (lesion/fat) enhancement on the first post contrast phase was 126.9% for Reader 1 and 88.4% for Reader 2.
